NCT00931320

Brief Summary

An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2009

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2009

Completed
1 day until next milestone

Study Start

First participant enrolled

July 1, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 2, 2009

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

October 27, 2009

Status Verified

October 1, 2009

First QC Date

June 30, 2009

Last Update Submit

October 23, 2009

Conditions

Dyslipidemias

Keywords

Ratio improvementLDL-CHDL-CRatio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol ImprovementHigh Density Lipoprotein Cholesterol

Outcome Measures

Primary Outcomes (1)

  • Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment)

    After Treatment : at least 4 weeks before statin taking /Baseline : no limitation.

Secondary Outcomes (1)

  • Evaluate difference of LDL/HDL ratio among different statins & dosages (between baseline & after treatment)

    After Treatment : at least 4 weeks before statin taking / Baseline : no limitation.

Study Arms (1)

3000 patients

Who have at least made 1 visit to the outpatient clinic within previous 6 months .

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Who have at least made 1 visit to the outpatient clinic within previous 6 months .

You may qualify if:

  • Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia
  • Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months
  • Subjects who have records of both LDL-C and HDL-C before \& after statin treatment (at least four weeks after statin taking)

You may not qualify if:

  • Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dyslipidemias

Condition Hierarchy (Ancestors)

Lipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Hyunah Caroline Choi

    AstraZeneca Korea

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

June 30, 2009

First Posted

July 2, 2009

Study Start

July 1, 2009

Study Completion

September 1, 2009

Last Updated

October 27, 2009

Record last verified: 2009-10